Houston-based 503B outsourcing facility specialising in producing antineoplastic medications and mitigating drug shortages Wilcrest Pharma announced on Friday that it has appointed AJ Day, PharmD, as its new chief executive officer.

Day is a dedicated advocate for compounded medicine and patient access, and has expertise in regulatory affairs and compounding supply chain.

Previously, Day served as vice president of Clinical Services at PCCA in Houston. He has worked on the National Community Pharmacists Association Compounding Steering Committee and as a board member for the Alliance for Pharmacy Compounding, Pharmacy Compounding Foundation and Texas Pharmacy Foundation. Day was also involved with various pharmacy groups, including the Society of Veterinary Hospital Pharmacists, American Society of Health-System Pharmacists and American Pharmacists Association.